W Fund
W Fund is a Seattle-based, early-stage venture capital fund founded in 2012 that invests seed capital of up to $500K in technology startups spinning out of the University of Washington and other Washington state research institutions, partnering with the Washington Research Foundation and a 20-member regional Investment Committee.
- Company typePrivate
- Founded2012
- HeadquartersSeattle, United States
- Headcount1–10
- GTM typeB2B
- OfferingServices
What W Fund does
W Fund is a Seattle-based, early-stage venture capital fund established in 2012 to provide seed and pre-seed capital to technology-based startup companies spinning out of the University of Washington and other Washington state research institutions. The fund operates with a five-member Board of Directors led by General Manager Linden Rhoads, former UW Vice Provost for Commercialization, and a 20-member Investment Committee that includes senior investment professionals from Madrona Venture Group, ARCH Venture Partners, WRF Capital, OVP, Point B Capital, and Alexandria Venture Investments. Its mandate explicitly covers spin-outs from Washington State University, Fred Hutchinson Cancer Research Center, Benaroya Research Institute, Seattle Children's Research Institute, Seattle Biomed, and Pacific Northwest National Laboratory, alongside the University of Washington's Center for Commercialization (C4C).
The fund's investment product is capital and ecosystem support: initial investments of up to $500K when participating in rounds of $1 million or more, with the option to lead alone and to make follow-on investments in portfolio companies. Entrepreneurs apply through the fund's website, selected companies present to a Screening Committee, and those that pass undergo due diligence and formal Investment Committee review. W Fund also operates the Student Venture Associates Program in collaboration with UW C4C and the Foster School's Center for Innovation and Entrepreneurship to give UW students experiential involvement in the diligence process. Portfolio companies span Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Tech/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS).
W Fund generates revenue through the standard venture capital model of management fees on committed capital and carried interest on successful portfolio exits. The fund was anchored by the Washington Research Foundation and UW Center for Commercialization with a stated target of investing approximately $20 million over four years. Its website currently indicates W Fund is no longer accepting new applications for investment consideration, consistent with the conclusion of its original investment period and a transition into portfolio harvest.
W Fund firmographics
Firmographics- Name
- W Fund
- Legal name
- W Fund
- Website
- https://thewfund.com
- Company type
- Private
- Founded year
- 2012
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- W Fund is a Seattle-based, early-stage venture capital fund founded in 2012 that invests seed capital of up to $500K in technology startups spinning out of the University of Washington and other Washington state research institutions, partnering with the Washington Research Foundation and a 20-member regional Investment Committee.
- Ownership category
- akta.pro rank
W Fund industry classification
Industry- Product category
- Venture Capital
- NAICS
- Other Investment Pools and Funds (5259)
- SIC
- Investment Advice (6282)
- akta.pro primary industry
- Early-Stage Venture Capital (Series A/B) (FSANAAAB)
Keywords
Where W Fund is headquartered
LocationHeadquarters
- HQ city
- Seattle
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
W Fund business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales
Revenue model
- Venture Capital Returns (Management Fees and Carried Interest): As an early-stage venture fund, W Fund generates returns through management fees on committed capital and carried interest on successful portfolio exits. The fund aims to invest approximately $20 million over four years across multiple portfolio companies, seeking to help startups reach venture-fundable milestones.
Go-to-market motion2 records
Distribution channels1 record
Marketing channels2 records
W Fund product offering
Product offeringCore offering
W Fund is an early-stage venture capital fund that makes seed and early-stage investments of up to $500K in technology-based startups spinning out of the University of Washington and other research institutions across Washington state. The fund targets participation in rounds of $1M or more, aims to invest approximately $20 million over four years, and seeks to bridge the gap between research and venture-fundable milestones through follow-on capital.
Product overview
W Fund is a venture capital firm, not a product company. The W Fund makes earliest-stage investments to accelerate the success of Washington's most promising technology-based start-up companies originating from research institutions and students across the state. The Fund targets initial investments of up to $500K and seeks to partner with other venture and angel groups on larger investments. Its portfolio companies span multiple sectors including Medical Devices (Aqueduct, Stasys, VICIS, NaviSonics, Cardiac Insight), Life Sciences (Beat BioTherapeutics, Cyrus Biotechnology, Nexgenia, Athira Pharma, Bellwether Bio, TwinStrand), Clean Technology/Materials/Engineering (HyperSciences, Lumisands, WiBotic, Olis Robotics), and Software/IT (AnswerDash, C-SATS). W Fund also operates the Student Venture Associates Program in collaboration with UW to provide experiential learning opportunities for students.
Differentiator
Problem solved
Functional benefit
Products and services
- Seed and Early-Stage Venture Capital Investment
Companies that use W Fund
Customer profileSegments1 record
Ideal customer profiles1 record
W Fund technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
W Fund partnerships and signals
Strategic signalPartnerships
Eight partnerships are on record, tiered core.
- University of Washington (Center for Commercialization / C4C)coreW Fund is the primary investment vehicle for spin-outs from the University of Washington's Center for Commercialization. The fund works closely with C4C to identify and evaluate promising research-based startups for investment.
- Washington State UniversitycoreW Fund invests in companies spinning out from Washington State University as part of its mandate to support research institution spin-outs across Washington state.
- Foster School's Center for Innovation and EntrepreneurshipcoreThe Student Venture Associates program was established by UW Center for Commercialization (C4C), funded by both C4C and Washington Research Foundation, working in collaboration with the Foster School's Center for Innovation and Entrepreneurship to provide experiential learning opportunities for UW students.
- Fred Hutchinson Cancer Research CentercoreW Fund invests in companies spinning out from Fred Hutchinson Cancer Research Center as part of its mandate to support Washington state research institution spin-outs.
- Benaroya Research InstitutecoreW Fund invests in companies spinning out from Benaroya Research Institute as part of its mandate to support Washington state research institution spin-outs.
- Seattle Children's Research InstitutecoreW Fund invests in companies spinning out from Seattle Children's Research Institute as part of its mandate to support Washington state research institution spin-outs.
- Seattle BiomedcoreW Fund invests in companies spinning out from Seattle Biomed as part of its mandate to support Washington state research institution spin-outs.
- Pacific Northwest National Laboratory (PNNL)coreW Fund invests in companies spinning out from Pacific Northwest National Laboratory as part of its mandate to support Washington state research institution spin-outs.
Scale indicators3 records
Recent moves6 records
Expansion highlights4 records
W Fund competitors and assessment
Company assessmentDirect peers
- WRF Capital: WRF Capital is the venture investment arm of the Washington Research Foundation and a co-investor/partner of W Fund. It invests in Washington state university spin-outs across life sciences and physical sciences, making it the most directly comparable peer.
- Alexandria Venture Investments: Alexandria's venture arm invests in early-stage life sciences companies, frequently participating in university spin-outs. Monica Beam (Alexandria) sits on W Fund's Investment Committee, indicating overlap in deal flow and investment focus area.
- Founders' Co-op: A Seattle-based pre-seed/seed venture fund focused on Pacific Northwest founders. Founders' Co-op invests at a similar earliest-stage and competes with W Fund for Washington state talent and spin-outs.
- Pioneer Fund: Pioneer Fund is a US early-stage venture fund investing in diverse founding teams, with a comparable pre-seed/seed check size and analogous limited-partner-driven fund structure typical of emerging VC firms.
Broad incumbents
- Madrona Venture Group: Pacific Northwest-focused early-to-growth-stage VC. While not exclusively university-focused, Madrona has institutional ties to UW and serves on W Fund's Investment Committee, representing the broader regional VC bench against which W Fund competes for deals.
- ARCH Venture Partners: ARCH is a large, established venture firm with deep biotech expertise; Steve Gillis (ARCH Managing Director) sits on W Fund's Investment Committee. ARCH represents the broader VC ecosystem that often co-invests in, or takes over, W Fund's university spin-outs.
- OVP (Obvious Ventures): Impact-oriented VC investing across IT, clean tech, and digital biology sectors. Chad Waite (OVP Managing Director) sits on W Fund's Investment Committee, representing an overlapping investment lens on tech-enabled, mission-driven companies.
- Point B Capital: Pacific Northwest-focused venture capital firm with software/IT emphasis. John Bjornson (Point B Capital President) sits on W Fund's Investment Committee, reflecting an institutional co-investor relationship that often takes over software/IT portfolio companies as they scale.
Regional players
- Element 8 Angels: Pacific Northwest cleantech-focused angel network. Jeff Canin (Element 8) sits on W Fund's Board, indicating co-investment partnership and overlap in clean-technology early-stage deals from Washington state research institutions.
Emerging players
- 1517 Fund: Alternative early-stage VC primarily backing young founders and alternative-path entrepreneurs. Operates at a similar earliest-stage seed check range to W Fund and competes for the same talent-driven university-adjacent pipeline.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
W Fund social profiles
Digital presenceW Fund financial estimates
Financial estimateRevenue estimate
Valuation estimate
W Fund leadership team
Management profileNumber of profiles
Profiles5 records
W Fund funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
W Fund M&A and investment
M&A and investmentM&A
Investments21 records
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about W Fund
What does W Fund do?
W Fund is an early-stage venture capital fund that makes seed and early-stage investments of up to $500K in technology-based startups spinning out of the University of Washington and other research institutions across Washington state. The fund targets participation in rounds of $1M or more, aims to invest approximately $20 million over four years, and seeks to bridge the gap between research and venture-fundable milestones through follow-on capital.
Is W Fund a public or private company?
W Fund is a private company. It is classified as unknown and is currently operating.
When was W Fund founded?
W Fund was founded in 2012. It employs 1 to 10 people.
Where is W Fund based?
W Fund is headquartered in Seattle, United States, in the North America region.
How does W Fund make money?
One revenue line is on record: venture Capital Returns (Management Fees and Carried Interest).
Who are W Fund's main competitors?
Direct peers on record are WRF Capital, Alexandria Venture Investments, Founders' Co-op and Pioneer Fund. Broad incumbents are Madrona Venture Group, ARCH Venture Partners, OVP (Obvious Ventures) and Point B Capital. Element 8 Angels is listed as a regional player. 1517 Fund is listed as an emerging player.
Does W Fund have an API?
No public API is recorded for W Fund.
What industry is W Fund in?
W Fund's product category is Venture Capital. Its primary akta.pro industry code is FSANAAAB, Early-Stage Venture Capital (Series A/B). Its NAICS code is 5259 and its SIC code is 6282.